Form 4: Clover Health CEO Jamie Reynoso Tax Withholding Filing

Clover Health CEO Jamie Reynoso reported the withholding of 12,712 shares to satisfy tax obligations related to RSU vesting.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health, had 12,712 shares of Class A Common Stock withheld.
• The transaction occurred on April 15, 2026, at a price of $2.04 per share.
• The withholding was mandatory to cover tax obligations resulting from the vesting of restricted stock units (RSUs).
• Following this transaction, the reporting person maintains a beneficial ownership of 2,857,210 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a mandatory administrative transaction related to compensation rather than a market-driven trade.

Positives

• The transaction was a routine administrative action related to tax obligations rather than a discretionary sale of stock.
• The reporting person retains a significant equity stake of 2,857,210 shares in the company.

Negatives

• None identified; this is a standard tax-related withholding event.

Risks

• Continued service requirements for the remaining unvested RSUs through October 15, 2028.

Future Outlook

The remaining RSUs are scheduled to vest in equal quarterly installments of 6.25% until the final vesting date on October 15, 2028, contingent upon continued service.

Management Comments

• The transaction represents shares automatically withheld to cover tax obligations due to the vesting of RSUs.

Industry Context

StockSavvy.ai notes that routine tax withholding filings are standard corporate governance practices for executives and do not typically signal changes in management sentiment or company outlook.

Comparison to Industry Standards

• The practice of withholding shares to cover tax liabilities upon RSU vesting is a standard industry practice for publicly traded companies in the healthcare and technology sectors.

Stakeholder Impact

• No material impact on shareholders or company operations.

Next Steps

• Continued quarterly vesting of remaining RSUs through October 15, 2028.

Key Dates

Keywords

Clover Health, CLOV, Insider Transaction, Form 4, Medicare Advantage, Equity Vesting